
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 2 157-161, Copyright © 1998 by American Association for Cancer Research
ARTICLES |
MR Karagas, ER Greenberg, LA Mott, JA Baron and VL Ernster
Department of Community and Family Medicine and the Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.
Epidemiological studies suggest that individuals with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) of the skin are more likely to develop other malignancies; however, the factors responsible for this are unknown. To clarify the risk of other cancers following the occurrence of BCC and SCC, we followed participants in a multicenter skin cancer prevention trial for subsequent malignancies. The study group consisted of 1805 BCC and SCC patients who had enrolled in a trial testing the efficacy of oral beta-carotene. Medical confirmation was sought for all cancers (other than BCC or SCC), which were reported by participants or their next-of-kin over a follow-up period of 10 years. We computed the rate ratio (RR) and 95% confidence interval (CI) of time to first new, primary cancer in relation to history of BCC and SCC, using a proportional hazards model. A total of 235 participants had a new primary invasive cancer during 13,887 person-years of follow up. The risk of other cancers was modestly elevated in patients with one or more previous SCCs compared with those who only had a history of BCC (adjusted RR, 1.37; 95% CI, 0.91-2.07). Risk of other cancers also appeared to be increased among those who had multiple prior BCCs relative to those who had only one prior BCC (adjusted RR, 1.21; 95% CI, 0.91-1.61). Further adjustment for smoking history, Quetelet index, radiotherapy, extent of actinic skin damage, treatment assignment, or baseline beta-carotene concentrations did not appreciably alter the results. Cancer of the respiratory system was most strongly related to previous SCC or multiple BCC [RRs (95% CI), 2.20 (1.05-4.62) and 2.34 (1.14-4.83), respectively]. Our data suggest that unidentified exposures or inherited risk factors may play a common etiological role in the pathogenesis of nonmelanoma skin cancer and other cancers, especially respiratory cancers, although larger studies would be necessary to exclude the role of chance in these findings.
This article has been cited by other articles:
![]() |
I. Soerjomataram, W. J. Louwman, V. E. P. P. Lemmens, J. W. W. Coebergh, and E. de Vries Are Patients with Skin Cancer at Lower Risk of Developing Colorectal or Breast Cancer? Am. J. Epidemiol., June 15, 2008; 167(12): 1421 - 1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. I Ibiebele, J. C van der Pols, M. C. Hughes, G. C Marks, G. M Williams, and A. C Green Dietary pattern in association with squamous cell carcinoma of the skin: a prospective study Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1401 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Nugent, A. A. Demers, M. C. Wiseman, C. Mihalcioiu, and E. V. Kliewer Risk of Second Primary Cancer and Death Following a Diagnosis of Nonmelanoma Skin Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2584 - 2590. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pandeya, D. M. Purdie, A. Green, and G. Williams Repeated Occurrence of Basal Cell Carcinoma of the Skin and Multifailure Survival Analysis: Follow-up Data from the Nambour Skin Cancer Prevention Trial Am. J. Epidemiol., April 15, 2005; 161(8): 748 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ramos, J. Villa, A. Ruiz, R. Armstrong, and J. Matta UV Dose Determines Key Characteristics of Nonmelanoma Skin Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2006 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Brewster, A. J. Alberg, P. T. Strickland, S. C. Hoffman, and K. Helzlsouer XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1271 - 1275. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |